- People
- Expertise
Our expertise
We are a team of more than 500 professionals, with the depth of experience which makes us genuine experts in our fields. Together, gunnercooke’s people have strength across just about every corporate discipline and sector. We provide legal, commercial and strategic advice that delivers real value to the clients we work with, which span from multinational enterprises through to unicorns and non-for-profit organisations. Our breadth of expertise covers some of the most interesting and important emerging disciplines, from ESG and charity law, to blockchain and competition.
Search by practice areaDispute ResolutionDispute Resolution OverviewMeet the Dispute Resolution TeamIntellectual Property DisputesFinancial Services & FinTech OverviewProceeds of CrimeEmployment TribunalTax InvestigationProperty Dispute ResolutionInsolvency DisputesMediationCivil Fraud & Asset TracingHealth & SafetyBusiness Crime & InvestigationsLitigation & ArbitrationInternational Arbitration - International
International Offices
The gunnercooke group has 15 main global offices across England, Scotland, the US, Germany and Austria, with further plans for growth in the coming years. These offices enhance the existing in-house capability of our dedicated international teams and dual-qualified experts that cover Spain, France, Italy, Portugal, Brazil, China, India, Poland and Hungary. Our team have clients across 123 jurisdictions, speak 46 languages and are dual-qualified in 21 jurisdictions. Our expertise means we can offer large teams to carry out complex cross-border matters for major international clients.
- Our story
Our story
gunnercooke is the fastest growing corporate law firm in the UK, now making its mark globally. We comprise a rapidly growing number of experts spanning legal and other disciplines. Clients benefit from flexible options on fees to suit their needs, access to a wider network of senior experts throughout the relationship, and legal advice which is complemented by an understanding of the commercial aspects of running a business.
- Reading Room
- News & Insights
gunnercooke Advises High Tide on €27.2 Million Entry into German Medical Cannabis Market
Canadian medical cannabis company High Tide Inc. has taken a significant step into the German market by acquiring a 51 per cent stake in Remexian Pharma GmbH, a major importer and wholesaler of medical cannabis. The deal, worth €27.2 million, also contains an option to purchase the remaining shares at a later stage.
Founded in 2018 near Berlin, Remexian has quickly become a key player in Germany’s medical cannabis sector. In the past twelve months, the company reported revenues of around €65 million and sold approximately seven tonnes of cannabis flower in the second quarter of 2025 alone, representing 16 per cent of the country’s import volume during that period.
International law firm gunnercooke advised High Tide throughout the acquisition, with Peter Homberg, partner and specialist in life sciences, intellectual property, corporate law and in the medical cannabis field, leading the team.
He was supported by a multidisciplinary team of gunnercooke lawyers including Judith Heimbürger and Malte Goetz, both counsel specialising in M&A and life sciences, Dr Matthias Döring, partner for commercial, corporate and M&A matters, Dr Karsten Umnuss, partner for employment and pensions, Thomas Schmidt, partner in real estate, Dr Christoph Dally, partner focusing on competition and antitrust, and Dr Franka Becker, partner in IT law. Each contributed their specialised expertise to ensure the legal, regulatory, and commercial aspects of the transaction were seamlessly addressed.
The transaction underscores Germany’s growing appeal as a hub for medical cannabis and reflects the increasing international interest in the European life sciences market. With annual sales approaching €1 billion, the sector presents significant opportunities for both domestic and international investors.
Peter Homberg commented: “High Tide’s investment represents a strategic entry into a rapidly expanding market. Germany’s medical cannabis sector is maturing quickly, and we are delighted to have supported our client in navigating the legal and regulatory complexities of this acquisition.”
To receive all the latest insights from gunnercooke to your inbox, sign up below